Zevra Therapeutics, Inc. (ZVRA) Free Cash Flow

Zevra Therapeutics, Inc. (ZVRA) free cash flow history and trends. Track FCF in Excel with MarketXLS.

Free Cash Flow Data

PeriodFree Cash Flow (USD)
2016-12-31-$30.41M
2017-12-31-$33.28M
2018-12-31-$54.22M
2019-12-31-$23.76M
2020-12-31-$1.97M
2021-12-31$10.34M
2022-12-31-$18.81M
2023-12-31-$33.83M
2024-12-31-$75.67M
2025-12-31-$2.43M

How ZVRA compares with sector peers

SymbolCompanyFree cash flow (latest fiscal year)
RMTIRockwell Medical Inc.-$1.24M
NMTCNeuroOne Medical Technologies Corporation-$2.92M
AXGNAxogen Inc.-$4.78M
PMCBPharmaCyte Biotech Inc.-$5.15M
DYAIDyadic International Inc.-$5.70M

These are five companies in the same sector as ZVRA with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.

Get Zevra Therapeutics, Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =hf_Free_Cash_Flow("ZVRA", 2024)

BUY NOW